Intelligence · Clinical Pipeline
Cognition Therapeutics Pipeline
All ClinicalTrials.gov programs at Cognition Therapeutics — phase, modality, and trial IDs.
- Programs
- 4
Quick answer
Cognition Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
300 mg [C14] CT1812
COGNITION THERAPEUTICS INC
Alzheimer Disease
1 trial -
CT1812
COGNITION THERAPEUTICS INC
Cognitive Impairment
1 trial -
CT1812
COGNITION THERAPEUTICS INC
Healthy Volunteers
1 trial -
Itraconazole
COGNITION THERAPEUTICS INC
Drug Interaction
1 trial
Frequently asked questions
How many pipeline programs does Cognition Therapeutics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs